go back

Lymphoma and Leukemia with Major Surgery (with CC)

Oklahoma rates for MS-DRG 821

Lymphoma and Leukemia with Major O.R. Procedures with CC

Rates data updated July 2026.

How much does Lymphoma and Leukemia with Major Surgery (with CC) cost?

$23,988

Typical facility fee. In Oklahoma, July 2026.

Insurers have agreed to pay about $23,988 for this service. Most negotiated rates run $17,378 to $30,903.

These are rates insurers have negotiated with providers, not the amount a patient is billed. What you owe depends on your plan's deductible and coinsurance. Based on rates published by 5 insurance carriers under federal price transparency rules.

How much rates vary

Facilitymedian $23,988 · 10th to 90th $15,136 to $38,905
$10K$20K$50Kfacility $23,988

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$12,022.64
Median
$26,302.68
Typical High
$34,673.69
BCBS
Setting
Facility
Modifier
Global
Typical Low
$15,848.93
Median
$23,988.33
Typical High
$39,810.72
Cigna
Setting
Facility
Modifier
Global
Typical Low
$14,791.08
Median
$30,902.95
Typical High
$44,668.36
Medica
Setting
Facility
Modifier
Global
Typical Low
$7,079.46
Median
$21,877.62
Typical High
$45,708.82
United
Setting
Facility
Modifier
Global
Typical Low
$7,413.10
Median
$22,387.21
Typical High
$41,686.94

Where Oklahoma sits

The same service costs 3.3 times more in New York than in New Mexico. Every bar is a state, most expensive first. Touch or drag across it to read any state, then open that state for its carriers and full range.

Oklahoma· 43rd of 51

$23,988

NY $58,884NM $17,783

Median negotiated rate in each state, from every insurer that publishes one. States where no insurer publishes a rate for this service are not shown.